Evolution of the Average Target: AstraZeneca PLC

Evolution of the Target Price: AstraZeneca PLC

Changes in Analyst Recommendations: AstraZeneca PLC

659419f9907.CsUpWJSwOfvmf6YEt7wUtCISEviFF5mkI7Xv8LNIlKk.OoQcIa3Dd5iVE8Bb5JF94BBna9XLUfKTTYOmxNc99f999hgi5MRDjrMX_w~777968166f58cbc0668053a22197cc0a
06:57pm Genmab in Good Health, Schneider Lacks Energy Zonebourse
04:02pm BofA Forecasts 'In-line' Q3, Unchanged FY26 Outlook for AstraZeneca Amid Oncology Momentum MT
30/09 AstraZeneca PLC : Deutsche Bank reaffirms its Neutral rating ZD
30/09 AstraZeneca's $2 Billion Investment in Summit Therapeutics Seen as 'Win-Win,' UBS Says MT
29/09 Stocks Defy the Pressure Zonebourse
29/09 AstraZeneca PLC : Jefferies keeps its Buy rating ZD
29/09 AstraZeneca PLC : RBC reaffirms its Buy rating ZD
29/09 AstraZeneca PLC : JP Morgan maintains a Buy rating ZD
29/09 AstraZeneca PLC : Deutsche Bank is Neutral ZD
18/09 Berenberg and Deutsche say buy Bytes Technology AN
16/09 AstraZeneca PLC : Gets a Buy rating from UBS ZD
16/09 Oddo BHF cuts Safestore to neutral, cuts target AN
16/09 AstraZeneca PLC : Buy rating from Jefferies ZD
16/09 AstraZeneca PLC : JP Morgan keeps its Buy rating ZD
16/09 AlphaValue/Baader Europe Notes GSK's Plans to Address Upcoming Patent Cliff; Price Target Down MT
16/09 Guardant Health Could Benefit From AstraZeneca Trial Failure, UBS Says MT
15/09 Deutsche Bank Upgrades AstraZeneca to Hold, Lifts PT MT
15/09 Berenberg Trims Price Target on AstraZeneca to $203 From $214, Keeps Buy Rating MT
15/09 Berenberg Maintains AstraZeneca at Buy as Pipeline Success Offsets Recent Setbacks; Price Target Down MT
15/09 Berenberg likes GSK; Deutsche Bank lifts Astra AN
15/09 AstraZeneca PLC : Berenberg keeps its Buy rating ZD
15/09 AstraZeneca PLC : Deutsche Bank withdraws its Sell rating ZD
14/09 AstraZeneca PLC : JP Morgan reiterates its Buy rating ZD
14/09 AstraZeneca PLC : Jefferies reiterates its Buy rating ZD
11/09 Berenberg Notes AstraZeneca's 'Stellar' Tozorakimab Late-stage Data; Buy Retained MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+16.25%
+10.5%
+4.93%
+12.05%
+7.67%
+8.24%
+34.74%
-2.99%
+9.7%
Average +11.23%
Weighted average by Cap. +11.85%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
155.54USD
Average target price
209.57USD
Spread / Average Target
+34.74%
High Price Target
267.78USD
Spread / Highest target
+72.17%
Low Price Target
157.72USD
Spread / Lowest Target
+1.40%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
-